Back to
Corient Private Wealth LP
AIM2 quarters
Position history for
Corient Private Wealth LP's holdings in AIM IMMUNOTECH INC COM NEW
No. Corient Private Wealth exited its AIM (Aim Immunotech) position in Q3 2025. Its Q2 2025 13F listed 10,001 shares worth $86,509. Corient Private Wealth first reported AIM in Q2 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$86,509
Total Shares Change
-10,001
Quarter-by-Quarter History
Other major holders of AIM: JANE STREET GROUP, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC